Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1

Clinical trial NCT06204809 · COMPLETED

Trial details

NCT number: NCT06204809
Sponsor: PepGen Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myotonic Dystrophy 1

Start date: 2023-12-12
Primary completion: 2025-10-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.